Portfolio company
Brain-to-Computer Interface
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops ultrasound-based brain-computer interfaces to treat neurological and psychiatric conditions for patients with unmet medical needs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Neuroharmonics
This company develops non-invasive ultrasound devices to modulate deep brain circuits for patients with movement disorders, depression, chronic pain, and addiction.
Ultra Bionics
The company develops implantable ultrasound technologies to provide neuromodulation and neurological disease therapies for patients with conditions such as Parkinson's and epilepsy.
Inner Cosmos
This company develops a minimally invasive brain-computer interface implant to treat cognitive disorders for patients suffering from depression.
Attune Neurosciences
This company develops wearable ultrasound neurostimulation devices for patients and government agencies to treat brain disorders and improve cognitive performance.
Innovative brain-machine interfaces
Merge Labs develops ultrasound-based, non-invasive brain-machine interfaces that link biological and artificial intelligence for individuals with neurological disorders and able-bodied users.
Neurotechnology company
This enterprise develops brain-computer interfaces for clinical research and patients with neurological conditions to restore communication and motor control through neural activity monitoring.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
Precision Neuroscience
Precision Neuroscience develops minimally invasive brain-computer interfaces to help patients with paralysis and neurological disorders control digital devices using their thoughts.
